[HTML][HTML] Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders
J Yamamoto, T Ito, Y Yamaguchi… - Chemical Society Reviews, 2022 - pubs.rsc.org
Progress in strategies aimed at breaking down therapeutic target proteins has led to a
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders
J Yamamoto, T Ito, Y Yamaguchi… - Chemical Society …, 2022 - pubmed.ncbi.nlm.nih.gov
Progress in strategies aimed at breaking down therapeutic target proteins has led to a
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
[PDF][PDF] TUTORIAL REVIEW
J Yamamoto, T Ito, Y Yamaguchia, H Handa - scholar.archive.org
1. Historical overview of thalidomide and its derivatives as pharmaceuticals. 2. Mechanism
of action of thalidomide and its derivatives at the molecular level. 3. The structure and …
of action of thalidomide and its derivatives at the molecular level. 3. The structure and …
[PDF][PDF] TUTORIAL REVIEW
J Yamamoto, T Ito, Y Yamaguchia, H Handa - researchgate.net
1. Historical overview of thalidomide and its derivatives as pharmaceuticals. 2. Mechanism
of action of thalidomide and its derivatives at the molecular level. 3. The structure and …
of action of thalidomide and its derivatives at the molecular level. 3. The structure and …
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders
J Yamamoto, T Ito, Y Yamaguchi, H Handa - Chemical Society Reviews, 2022 - cir.nii.ac.jp
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development
of protein degraders | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
of protein degraders | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders.
J Yamamoto, T Ito, Y Yamaguchi… - Chemical Society …, 2022 - europepmc.org
Progress in strategies aimed at breaking down therapeutic target proteins has led to a
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
paradigm shift in drug discovery. Thalidomide and its derivatives are the only protein …
[引用][C] Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders
伊藤拓水， 山口雄輝 - Chemical Society Reviews, 2022 - cir.nii.ac.jp
Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development
of protein degraders | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
of protein degraders | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …